Our Treatment Approach
The Adult Leukemia Program is part of Dana-Farber Brigham Cancer Center's Center for Hematologic Oncology, one of the world's largest and most respected treatment centers for patients with disorders of the blood or bone marrow. Our Program cares for a high number of patients with Acute Lymphoblastic Leukemia (ALL) and has expertise developing appropriate treatment plans based on age and ALL subtype.
Treatment for ALL is determined by:
- Your age
- Your subtype of ALL (B cell or T cell, and if you have the Philadelphia chromosome)
- Whether you are newly-diagnosed or your disease has relapsed
- If a clinical trial is appropriate for your care
Your care will include the latest and best treatments available, including clinical trials of new therapies based on research in our laboratories and elsewhere in the field. We have tailored treatment plans for both young adults and older adults. You also have the full range of support services from a top-ranked hospital and leading cancer research center.
Team Approach
At Dana-Farber Brigham Cancer Center, you receive world-class care from a team of specialists with expertise in caring for adults with ALL. We have extensive experience in standard and novel therapies to ensure that your care plan offers the best possible outcomes. We work closely with our stem cell/bone marrow transplant team when patients require transplantation to ensure early evaluation and a smooth and fast transition to transplantation. We also work closely with colleagues in pediatrics, social work, psychiatry, geriatrics, nutrition, and others to address the specific needs of each patient.